Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5976
Norwood Financial Corp
NWFL
$370M
| $30K | ﹤0.01% |
911
+702
| +336% | +$21.3K |
|
5977
Orrstown Financial Services
ORRF
$840M
| $30K | ﹤0.01% |
1,176
+1,004
| +584% | +$25.4K |
|
5978
Cartesian Therapeutics
RNAC
$229M
| $30K | ﹤0.01% |
101
+45
| +80% | +$19.7K |
|
5979
PUT
ProShares UltraShort Yen
YCS
$29.9M
| $30K | ﹤0.01% |
+1,600
| New | +$30K |
|
5980
Arq
ARQ
$84.6M
| $30K | ﹤0.01% |
3,137
+2,381
| +315% | +$25.4K |
|
|
DCPH
5981
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $30K | ﹤0.01% |
1,308
-23,692
| -95% | -$464K |
|
|
NS
5982
CALL
DELISTED
NuStar Energy L.P.
NS
| $30K | ﹤0.01% |
1,000
-1,200
| -55% | -$38.9K |
|
|
ESXB
5983
DELISTED
Community Bankers Trust Corporation
ESXB
| $30K | ﹤0.01% |
3,600
+3,001
| +501% | +$25.9K |
|
|
PFBI
5984
DELISTED
Premier Financial Bancorp
PFBI
| $30K | ﹤0.01% |
1,865
+1,591
| +581% | +$25.6K |
|
|
MBTF
5985
DELISTED
MBT Financial Corporation
MBTF
| $30K | ﹤0.01% |
2,827
+2,414
| +585% | +$25.7K |
|
|
REIS
5986
DELISTED
Reis, Inc.
REIS
| $30K | ﹤0.01% |
1,437
+1,227
| +584% | +$23.7K |
|
|
GST
5987
DELISTED
Gastar Exploration Inc.
GST
| $30K | ﹤0.01% |
28,612
-20,533
| -42% | -$17.9K |
|
|
BWP
5988
CALL
DELISTED
Boardwalk Pipeline Partners
BWP
| $30K | ﹤0.01% |
2,300
-17,300
| -88% | -$245K |
|
|
MEET
5989
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $30K | ﹤0.01% |
10,623
+9,071
| +584% | +$27K |
|
5990
CALL
iShares MSCI ACWI ETF
ACWI
$32.9B
| $29K | ﹤0.01% |
400
-301,600
| -100% | -$21.3M |
|
5991
Blue Bird Corp
BLBD
$2.35B
| $29K | ﹤0.01% |
1,479
+1,109
| +300% | +$22K |
|
5992
Consolidated Water Co
CWCO
$467M
| $29K | ﹤0.01% |
2,317
+1,977
| +581% | +$25K |
|
5993
Duluth Holdings
DLTH
$155M
| $29K | ﹤0.01% |
1,609
-30,598
| -95% | -$566K |
|
5994
CALL
Energy Recovery
ERII
$446M
| $29K | ﹤0.01% |
3,300
-6,900
| -68% | -$62.9K |
|
5995
Forte Biosciences
FBRX
$1.57B
| $29K | ﹤0.01% |
8
-14
| -64% | -$55.9K |
|
5996
LCNB Corp
LCNB
$282M
| $29K | ﹤0.01% |
1,406
+1,201
| +586% | +$25K |
|
5997
LSI Industries
LYTS
$859M
| $29K | ﹤0.01% |
4,155
+3,129
| +305% | +$21.1K |
|
5998
NACCO Industries
NC
$357M
| $29K | ﹤0.01% |
788
-1,160
| -60% | -$46.6K |
|
5999
NWPX Infrastructure Inc
NWPX
$1.19B
| $29K | ﹤0.01% |
1,513
+630
| +71% | +$11.7K |
|
6000
Dr. Reddy's Laboratories
RDY
$9.87B
| $29K | ﹤0.01% |
3,805
+1,050
| +38% | +$7.56K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.